-
Payer Views on Prescription Digital Therapeutics in the US and Canada
-
How Does Biosimilar Availability Create Value for the Patient? A Conversation About Avenues to Widen Access to Biologics
-
External Control Arms - Application, Key Methods, and Acceptability
-
Applications of Large Language Models for RWD Analytics
-
October 4-5: Analysis of Longitudinal Data: Fixed and Random Effects Models- Virtual
-
Harnessing Horses and Zebras in Predictive Analytics: Methodological Considerations for Extreme Population Sizes in Real-World Evidence Generation
-
How to Drive Value in the Digital Transformation Era?
-
Application of Distributional Cost-Effectiveness Analysis to the US Setting
-
Innovative Uses of Technology to Advance Health Preference Research
-
The Use of Real-World Evidence in HTA in Central and Eastern Europe
-
Communicating High Value in Scientific Publications
-
September 6-7: Targeted Learning for Generating Real-World Evidence in Evolving Regulatory Landscape-Virtual
-
August 22-23: Selecting Rapid Review Methods for Health Technology Assessment- Virtual
-
Driving Health Outcomes: Exploring Value-Based Procurement
-
August 7-8: Economic Model Review: Quality Control, Strategic Assessment and Reporting Standards- Virtual
-
Health is Wealth
-
July 25-26: Model Calibration in R- Virtual
-
Economic Evaluation of Digital Health Technologies
-
July 19: Learning and Applying Discrete Event Simulation- Virtual
-
Assessing Causal Treatment Effect for Sequenced Oncology Regimens